Bridgeway Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-174,800
| Closed | -$1.59M | – | 1479 |
|
|
2018
Q1 | $1.59M | Sell |
174,800
-120,000
| -41% | -$1.09M | 0.02% | 670 |
|
|
2017
Q4 | $1.26M | Sell |
294,800
-40,000
| -12% | -$171K | 0.01% | 753 |
|
|
2017
Q3 | $472K | Hold |
334,800
| – | – | 0.01% | 1111 |
|
|
2017
Q2 | $502K | Buy |
334,800
+139,000
| +71% | +$208K | 0.01% | 1089 |
|
|
2017
Q1 | $503K | Hold |
195,800
| – | – | 0.01% | 1073 |
|
|
2016
Q4 | $499K | Hold |
195,800
| – | – | 0.01% | 1093 |
|
|
2016
Q3 | $605K | Hold |
195,800
| – | – | 0.01% | 1005 |
|
|
2016
Q2 | $629K | Buy |
195,800
+20,900
| +12% | +$67.1K | 0.01% | 950 |
|
|
2016
Q1 | $542K | Hold |
174,900
| – | – | 0.01% | 1013 |
|
|
2015
Q4 | $701K | Hold |
174,900
| – | – | 0.01% | 913 |
|
|
2015
Q3 | $801K | Hold |
174,900
| – | – | 0.02% | 829 |
|
|
2015
Q2 | $908K | Buy |
174,900
+50,000
| +40% | +$260K | 0.02% | 826 |
|
|
2015
Q1 | $782K | Hold |
124,900
| – | – | 0.02% | 897 |
|
|
2014
Q4 | $786K | Buy |
+124,900
| New | +$786K | 0.02% | 867 |
|